Latest Insider Transactions at Keros Therapeutics, Inc. (KROS)
This section provides a real-time view of insider transactions for Keros Therapeutics, Inc. (KROS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Keros Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Keros Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,900
-15.65%
|
$954,000
$60.0 P/Share
|
|
Nov 10
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,900
+13.53%
|
$0
$0.3 P/Share
|
|
Nov 04
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,600
-11.01%
|
$530,000
$50.0 P/Share
|
|
Nov 04
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,600
+9.92%
|
$0
$0.3 P/Share
|
|
Nov 03
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
15,967
-1.17%
|
$670,614
$42.05 P/Share
|
|
Nov 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
7,881
-0.57%
|
$331,002
$42.57 P/Share
|
|
Nov 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,803
-1.67%
|
$999,726
$42.14 P/Share
|
|
Oct 20
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,082
-0.28%
|
$151,034
$37.93 P/Share
|
|
Oct 19
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,516
-0.31%
|
$171,608
$38.27 P/Share
|
|
Oct 18
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
13,786
-0.93%
|
$523,868
$38.07 P/Share
|
|
Oct 15
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
8,198
-0.37%
|
$319,722
$39.66 P/Share
|
|
Oct 14
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,383
-0.58%
|
$175,320
$40.13 P/Share
|
|
Oct 05
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
2,617
-0.35%
|
$104,680
$40.03 P/Share
|
|
Oct 04
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
3,746
-0.49%
|
$149,840
$40.06 P/Share
|
|
Oct 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
6,323
-0.82%
|
$252,920
$40.16 P/Share
|
|
Sep 27
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
95,302
-3.82%
|
$3,907,382
$41.44 P/Share
|
|
Aug 17
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,293
+1.49%
|
$0
$0.3 P/Share
|
|
Jul 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,818
-1.35%
|
$976,538
$41.4 P/Share
|
|
Jul 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,834
-0.87%
|
$977,194
$41.95 P/Share
|
|
Jun 24
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+7.15%
|
$0
$0.3 P/Share
|
|
Jun 11
2021
|
Claudia Ordonez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-82.65%
|
$51,000
$51.22 P/Share
|
|
Jun 11
2021
|
Claudia Ordonez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$0
$0.48 P/Share
|
|
Jun 11
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,650
-1.11%
|
$135,150
$51.41 P/Share
|
|
Jun 11
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,650
+3.18%
|
$0
$0.3 P/Share
|
|
Jun 07
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
12,796
-0.23%
|
$627,004
$49.14 P/Share
|
|
Jun 04
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
6,619
-0.36%
|
$311,093
$47.69 P/Share
|
|
Jun 03
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
7,895
-0.42%
|
$371,065
$47.92 P/Share
|
|
Jun 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
11,529
-0.3%
|
$564,921
$49.9 P/Share
|
|
Jun 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
8,812
-0.23%
|
$467,036
$53.25 P/Share
|
|
May 13
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,720
+4.04%
|
$0
$0.21 P/Share
|
|
May 11
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,650
-3.59%
|
$132,500
$50.0 P/Share
|
|
May 11
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,650
+3.46%
|
$0
$0.3 P/Share
|
|
May 11
2021
|
Claudia Ordonez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$50,000
$50.15 P/Share
|
|
May 11
2021
|
Claudia Ordonez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$0
$0.48 P/Share
|
|
May 04
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
2,835
-0.15%
|
$153,090
$54.04 P/Share
|
|
May 03
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
44,816
-0.91%
|
$2,554,512
$57.76 P/Share
|
|
Apr 12
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,300
-1.76%
|
$318,000
$60.47 P/Share
|
|
Apr 12
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+6.48%
|
$0
$0.3 P/Share
|
|
Apr 12
2021
|
Claudia Ordonez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-67.06%
|
$60,000
$60.11 P/Share
|
|
Apr 12
2021
|
Claudia Ordonez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$0
$0.48 P/Share
|
|
Apr 06
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
9,298
-0.31%
|
$548,582
$59.09 P/Share
|
|
Apr 05
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
27,151
-0.87%
|
$1,601,909
$59.56 P/Share
|
|
Apr 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
11,202
-0.27%
|
$660,918
$59.92 P/Share
|
|
Apr 01
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,996
+12.31%
|
$0
$0.11 P/Share
|
|
Mar 11
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,300
-2.71%
|
$339,200
$64.73 P/Share
|
|
Mar 11
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+7.38%
|
$0
$0.3 P/Share
|
|
Mar 11
2021
|
Claudia Ordonez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-69.75%
|
$64,000
$64.47 P/Share
|
|
Mar 11
2021
|
Claudia Ordonez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$0
$0.48 P/Share
|
|
Mar 04
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
11,632
-0.22%
|
$651,392
$56.17 P/Share
|
|
Mar 03
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
12,327
-0.29%
|
$702,639
$57.38 P/Share
|